Under the Production Linked Incentive (PLI) scheme, Lyfius Pharma Private Limited (Lyfius Pharma) invested ₹2,500 crores in Penicillin-G (Pen-G) facility Commercial production to ramp up in FY25, enhancing domestic production of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs) Lyfius Pharma
Dr. Parimala V Thirumalesh, Sr. Consultant - Neonatology & Pediatrics, Aster CMI Hospital, Bangalore World Polio Day is marked internationally on October 24 every year. It is a necessary awareness for the battle of polio. It is a viral disease that mainly affects children below the
OneSource Specialty Pharma, a newly formed CDMO, is formed from the merger of three CDMO businesses within the Strides Group, which boasts a 30-year track-record of excellence in manufacturing and quality. The company is launching its new brand identity with a strong emphasis on customer
Mankind Pharma, a reputed global pharmaceutical firm, executed a Business Transfer Agreement (BTA) to transfer its Over-the-Counter (OTC) business undertaking to its wholly owned subsidiary, Mankind Consumer Products Private Limited (MCPPL), on a slump sale basis. In Q1 FY25, the OTC business reported revenues of
Marketing approvals for bortezomib from Philippines and carboplatin from Morocco will enable the company to enhance its presence in ASEAN, African regions Venus Remedies Ltd, a prominent oncology drug manufacturer, has secured marketing authorizations for two key cancer drugs, enhancing its global reach. The approvals
In a significant move to address chronic kidney disease (CKD) complications, Zydus Lifesciences has announced a collaborative research agreement with the Lucknow-based CSIR-Central Drug Research Institute (CDRI) to develop an innovative oral medication targeting chronic kidney disease-induced osteoporosis. The partnership will focus on discovering small molecule
Rising Antimicrobial Resistance Poses Critical Threat to Neurocritical Care Patients ~ Leading Neurocritical Care Experts Convened at the highly successful 7th Annual National Conference of the Society of Neurocritical Care of India (SNCC) on September 21-22, 2024, Mumbai to address the pressing need for novel anti-infective treatments in
The Indian pharmaceuticals sector is poised for robust revenue growth of 8-10% this fiscal year, building on last year's approximately 10% increase. This growth is attributed to strong exports to regulated markets, a rebound in semi-regulated markets, and consistent domestic demand.Improved Operating Margins As a result
Cipla Ltd. made headlines on Tuesday with a significant update regarding its board of directors. Mustafa Khwaja Hamied, commonly known as MK Hamied, will step down from his role as vice-chairman and non-executive director. The resignation will be effective at the close of business on
Entod Pharmaceuticals has announced that it has received final approval from the Drug Controller General of India (DCGI) for its groundbreaking PresVu eye drops. This approval, disclosed during a press conference held today in New Delhi, follows a favorable recommendation by the Subject Expert Committee
